Contents: Research LetterFecal Microbiota Transplantation for the Treatment of Refractory Recurrent Urinary Tract InfectionJeney, Sarah E. S. MD; Lane, Felicia MD, MS; Oliver, Andrew MS; Whiteson, Katrine PhD; Dutta, Sonia MDAuthor Information Department of Obstetrics & Gynecology and the School of Biological Sciences, University of California, Irvine, Irvine, California; and the Department of Obstetrics & Gynecology, NorthShore University HealthSystem, Skokie, Illinois. Corresponding author: Sarah E.S. Jeney, MD, Department of Obstetrics & Gynecology, University of California, Irvine, Irvine, CA; email: [email protected]. Funding for this study was granted by The Fry Family Foundation. Financial Disclosure Felicia Lane disclosed receiving funds from Axonics. The other authors did not report any potential conflicts of interest. Presented at the 1st Urobiome Meeting, February 26, 2019, La Jolla, California, and at the AUGS/IUGA Joint Scientific Meeting, September 24–28, 2019, Nashville, Tennessee. The authors thank Zymo Research Corp (Irvine, CA) for their contracted DNA extraction, sequencing, and analysis and Jenny Chang, MS for assistance in statistical calculations. Each author has confirmed compliance with the journal's requirements for authorship. Peer reviews and author correspondence are available at http://links.lww.com/AOG/C5. Obstetrics & Gynecology: October 2020 - Volume 136 - Issue 4 - p 771-773 doi: 10.1097/AOG.0000000000004052 Buy SDC Metrics Fecal microbiota transplantation may reduce urinary tract infection by altering the gut microbiome. © 2020 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.